iRhythm demonstrates value in 14-day monitoring for arrhythmia recurrence

iRhythm demonstrates value in 14-day monitoring for arrhythmia recurrence

Summary

Two of iRhythm's retrospective studies detected arrhythmias beyond 48 hours in 30% of patients post-cardiac ablation and in 60% of pregnant patients.

Description

Two of iRhythm's retrospective studies detected arrhythmias beyond 48 hours in 30% of patients post-cardiac ablation and in 60% of pregnant patients.

Original reporting

AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.

Open original source